Genmab A/S (GMAB) Analyst & Key Data

Analyst Consensus

Buy12 analysts

Buy

Updated Sep 12, 2026

Total Analysts12

Buy

13

Hold

4

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score4.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$32.47

Median Target+25.13%

$40.63

Potential upside vs current price

DCF Value-83.41%

$5.39

Potential downside vs current price

Current Stock Price

$32.47

Median Target+25.13%

$40.63

Potential upside vs current price

DCF Value-83.41%

$5.39

Potential downside vs current price

Analyst Consensus

Buy12 analysts

Buy

Updated Sep 12, 2026

Total Analysts12

Buy

13

Hold

4

Sell

1

Ratings

Updated Sep 12, 2026

Overall Rating

B

DCF Score3.0 / 5

Debt / Equity Score1.0 / 5

Price / Book Score2.0 / 5

Price / Earnings Score2.0 / 5

ROA Score4.0 / 5

ROE Score4.0 / 5

Valuation

Current Stock Price

$32.47

Median Target+25.13%

$40.63

Potential upside vs current price

DCF Value-83.41%

$5.39

Potential downside vs current price

Current Stock Price

$32.47

Median Target+25.13%

$40.63

Potential upside vs current price

DCF Value-83.41%

$5.39

Potential downside vs current price